drugset / Trial / NCT05600322

Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer

NCT05600322

NaSingle-groupOpen-labelDiagnostic

Summary

A study to compare Hexvix Blue light cstoscopy with standard White light cystoscopy in the detection of bladder cancer.

Timeline

Start
2022-11-03
Primary completion
2023-07-12
Completion
2023-07-12

Drugs

EvaluationDrugModalityDoseRoute
Subject hexaminolevulinate Small molecule 50 ml Intravenous